<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03886961</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201900469 -A</org_study_id>
    <nct_id>NCT03886961</nct_id>
  </id_info>
  <brief_title>The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients</brief_title>
  <acronym>Reflux Band</acronym>
  <official_title>The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, open label, study designed to assess the affect of the Reflux Band® UES Assist
      Device (Reflux Band) on reflux in patients that have undergone lung transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2019</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pepsin levels</measure>
    <time_frame>Baseline; Week 4; Week 8</time_frame>
    <description>The presence of reflux will be assessed by measuring levels of pepsin in bronchoalveolar lavage fluid.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in amylase levels</measure>
    <time_frame>Baseline; Week 4; Week 8</time_frame>
    <description>The presence of reflux will be assessed by measuring levels of amylase in bronchoalveolar lavage fluid.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Lung Transplant</condition>
  <condition>GERD</condition>
  <arm_group>
    <arm_group_label>Lung Transplant Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For the first four weeks, lung transplant patients will not wear the Reflux Band. Use of the Reflux Band will subsequently commence in the next four weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Reflux Band</intervention_name>
    <description>The Reflux Band is to be worn when sleeping by lung transplant patients for 4 weeks starting 8 weeks after transplant.</description>
    <arm_group_label>Lung Transplant Patients</arm_group_label>
    <other_name>Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinically stable lung transplant patients(single lung, double lung, or re-transplant)
             as defined by stable FEV1 over the prior two visits

          -  13 Abnormal pH impedence or esophagram or documented gastric reflux at pre-transplant
             evaluation

          -  Patient must be willing and able to provide informed consent

          -  Understands the clinical study requirements and is able to comply with follow-up
             schedule

        Exclusion Criteria:

          -  Currently being treated with another investigational medical device and/or drug

          -  Currently receiving treatment for sleep apnea with continuous positive airway pressure
             (CPAP)

          -  Previous head or neck surgery / radiation

          -  Carotid artery disease, thyroid disease, or history of cerebral vascular disease

          -  Nasopharyngeal cancer

          -  Suspected esophageal cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andres Pelaez Freidel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vanessa Scheuble</last_name>
    <phone>352-273-7589</phone>
    <email>Vanessa.Scheuble@medicine.ufl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UF Health at the University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 21, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2019</study_first_posted>
  <last_update_submitted>May 19, 2020</last_update_submitted>
  <last_update_submitted_qc>May 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

